experimental group:thalidomide

2 trials

Sponsors

Renji Hospital School of Medicine Shanghai Jiao Tong University, West China Hospital of Stomatology, Sichuan University

Conditions

recurrent aphthous ulcerationurmia pruritus

Early Phase 1

A prospective, single-arm, single-center clinical study of the preliminary safety and efficacy of thalidomide in the treatment of refractory uremic pruritus

Active, not recruitingChiCTR2100053515

Renji Hospital School of Medicine Shanghai Jiao Tong Universityurmia pruritus

Start: 2021-12-20Updated: 2023-07-16

Phase 4

The evaluation on the efficacy of thalidomide reducing the recurrence frequency of RAU

Active, not recruitingChiCTR-IPR-17011608

West China Hospital of Stomatology, Sichuan Universityrecurrent aphthous ulceration

Start: 2017-09-01Updated: 2017-06-12